Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan for intestinal function after cardiopulmonary resuscitation
ChiCTR1900026531Phase 4Not yet recruiting
- Sponsor
- Renji Hospital
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of levosimendan in post-cardiac arrest syndrome (PCAS) and Acute Heart Failure (AHF) (2 arms), sponsored by Renji Hospital. Primary endpoint: Percentage of patients with the Pouchot score dropped by more than two points. Planned start Oct 2019; status: not yet recruiting.
02
Drugs
levosimendan
03
Conditions
post-cardiac arrest syndrome (PCAS)Acute Heart Failure (AHF)
Beyond the preview
Go deeper on ChiCTR1900026531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026531.